Despite advances in our understanding of appendiceal mucinous neoplasms and their
relationship to the pseudomyxoma peritonei syndrome, the classification of mucinous tumors …

Abstract High-throughput “-omics” analysis may provide a broader and deeper
understanding of cancer biology to define prognostic and predictive biomarkers and identify …

Background Mucinous neoplasms of the appendix (MNA) are rare tumors which may
progress from benign to malignant disease with an aggressive biological behavior. MNA is …

Pseudomyxoma peritonei (PMP) is a relatively rare clinical syndrome characterized by
neoplastic epithelial cells growing in the peritoneal cavity and secreting mucinous ascites …

We analyzed a series of 55 disseminated appendiceal mucinous neoplasms treated at our
institution for GNAS and KRAS mutations in an attempt to correlate mutation status with …

Pseudomyxoma peritonei (PMP) is a rare disease exhibiting a distinct clinical feature
caused by cancerous cells that produce mucinous fluid in the abdominal cavity. PMP s …

Purpose Pseudomyxoma peritonei (PMP) is a rare clinical malignancy syndrome
characterized by the uncontrollable accumulation of copious mucinous ascites in the …

Background Pseudomyxoma peritonei (PMP) is an extremely rare malignancy,
characterized by extensive peritoneal implantation and colloidal ascites. This study was to …

Pseudomyxoma peritonei (PMP) is a clinical syndrome characterized by gross mucinous
ascites originating from a disseminated intraperitoneal neoplasm. Although typically …

Background Mutations activating the α subunit of heterotrimeric Gs protein are associated
with a number of highly specific pathological molecular phenotypes. One of the best …